Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes
Publication date: January 2027 Source: American Heart Journal, Volume 303 Author(s): Sharine Wittkopp, Parsa Asachi, Filipp Kazatsker, Souptik Barua, José O. Alemán, Terry Gordon, Robert D. Brook, Lorna E. Thorpe, Jonathan D. Newman
Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes. // American Journal of Kidney Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0002870326002358?dgcid=rss_sd_all
Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes. American Journal of Kidney Diseases. https://www.sciencedirect.com/science/article/pii/S0002870326002358?dgcid=rss_sd_all
“Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes.” American Journal of Kidney Diseases.
@article{article3282,
title = {Cleaner air for lower cardiometabolic risk: Protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes},
journal = {American Journal of Kidney Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0002870326002358?dgcid=rss_sd_all}
}